Givosiran
Givosiran (ALN-AS1) is a small interfering RNA compound that selectively targets hepatic aminolevulinate synthase 1 (ALAS1) mRNA, leading to efficient downregulation of ALAS1 expression and consequent inhibition of neurotoxic δ-aminolevulinic acid and porphobilinogen accumulation. Givosiran provides a mechanism-driven research tool with significant relevance for studying metabolic dysregulation and therapeutic intervention strategies in acute intermittent porphyria.
Product Specifications
CAS Number
1639325-43-1
Purity
99.88% (May vary between batches)
Molecular Weight
16300.60
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15131910 1 Vial
Lentiviral human AUTS2 shRNA (UAS) - Lentiviral human AUTS2 shRNA (UAS) (100)
Sign In for Pricing
View Details 
A14889-iFluor647 100 µg
Anti-TMEM240 Antibody Picoband® (iFluor647 Conjugate)
Sign In for Pricing
View Details 
MBS6150970-01 0.1 mL
RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (HRP)
Sign In for Pricing
View Details MBS6150970-02 5x 0.1 mL
RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (HRP)
Sign In for Pricing
View Details